Waters Parkerson & Co’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.8M | Sell |
10,667
-6
| -0.1% | -$6.13K | 0.63% | 42 |
|
|
2026
Q1 | $9.82M | Sell |
10,673
-57
| -0.5% | -$57.8K | 0.5% | 46 |
|
|
2025
Q4 | $11.5M | Sell |
10,730
-121
| -1% | -$116K | 0.57% | 45 |
|
|
2025
Q3 | $8.28M | Sell |
10,851
-46
| -0.4% | -$34.2K | 0.4% | 49 |
|
|
2025
Q2 | $8.49M | Sell |
10,897
-91
| -0.8% | -$70.7K | 0.42% | 53 |
|
|
2025
Q1 | $9.08M | Buy |
10,988
+241
| +2% | +$201K | 0.48% | 52 |
|
|
2024
Q4 | $8.3M | Buy |
10,747
+208
| +2% | +$172K | 0.44% | 53 |
|
|
2024
Q3 | $9.34M | Buy |
10,539
+34
| +0.3% | +$30.6K | 0.47% | 51 |
|
|
2024
Q2 | $9.51M | Sell |
10,505
-306
| -3% | -$245K | 0.51% | 51 |
|
|
2024
Q1 | $8.41M | Buy |
10,811
+463
| +4% | +$330K | 0.43% | 52 |
|
|
2023
Q4 | $6.03M | Buy |
10,348
+453
| +5% | +$264K | 0.33% | 54 |
|
|
2023
Q3 | $5.32M | Sell |
9,895
-153
| -2% | -$78.8K | 0.32% | 54 |
|
|
2023
Q2 | $4.71M | Sell |
10,048
-25
| -0.2% | -$10.5K | 0.27% | 56 |
|
|
2023
Q1 | $3.46M | Hold |
10,073
| – | – | 0.2% | 57 |
|
|
2022
Q4 | $3.69M | Sell |
10,073
-897
| -8% | -$318K | 0.22% | 56 |
|
|
2022
Q3 | $3.55M | Buy |
10,970
+290
| +3% | +$91.9K | 0.24% | 57 |
|
|
2022
Q2 | $3.46M | Buy |
10,680
+115
| +1% | +$34.5K | 0.22% | 56 |
|
|
2022
Q1 | $3.02M | Sell |
10,565
-141
| -1% | -$36.3K | 0.17% | 59 |
|
|
2021
Q4 | $2.96M | Buy |
10,706
+52
| +0.5% | +$13.2K | 0.16% | 59 |
|
|
2021
Q3 | $2.46M | Sell |
10,654
-435
| -4% | -$107K | 0.14% | 65 |
|
|
2021
Q2 | $2.54M | Hold |
11,089
| – | – | 0.15% | 66 |
|
|
2021
Q1 | $2.07M | Hold |
11,089
| – | – | 0.13% | 70 |
|
|
2020
Q4 | $1.87M | Hold |
11,089
| – | – | 0.13% | 69 |
|
|
2020
Q3 | $1.64M | Hold |
11,089
| – | – | 0.12% | 68 |
|
|
2020
Q2 | $1.82M | Hold |
11,089
| – | – | 0.15% | 66 |
|
|
2020
Q1 | $1.54M | Buy |
11,089
+120
| +1% | +$16.5K | 0.15% | 68 |
|
|
2019
Q4 | $1.44M | Sell |
10,969
-400
| -4% | -$46.4K | 0.11% | 75 |
|
|
2019
Q3 | $1.27M | Hold |
11,369
| – | – | 0.1% | 77 |
|
|
2019
Q2 | $1.26M | Sell |
11,369
-1,000
| -8% | -$118K | 0.1% | 77 |
|
|
2019
Q1 | $1.6M | Sell |
12,369
-3,316
| -21% | -$403K | 0.13% | 70 |
|
|
2018
Q4 | $1.81M | Sell |
15,685
-600
| -4% | -$67K | 0.18% | 65 |
|
|
2018
Q3 | $1.75M | Buy |
16,285
+130
| +0.8% | +$13K | 0.14% | 68 |
|
|
2018
Q2 | $1.38M | Sell |
16,155
-668
| -4% | -$54.9K | 0.12% | 71 |
|
|
2018
Q1 | $1.3M | Sell |
16,823
-25
| -0.1% | -$2.01K | 0.11% | 70 |
|
|
2017
Q4 | $1.42M | Sell |
16,848
-250
| -1% | -$21.3K | 0.12% | 69 |
|
|
2017
Q3 | $1.46M | Buy |
17,098
+3,125
| +22% | +$256K | 0.13% | 72 |
|
|
2017
Q2 | $1.15M | Hold |
13,973
| – | – | 0.11% | 78 |
|
|
2017
Q1 | $1.18M | Sell |
13,973
-500
| -3% | -$40K | 0.11% | 78 |
|
|
2016
Q4 | $1.06M | Sell |
14,473
-350
| -2% | -$26.1K | 0.11% | 78 |
|
|
2016
Q3 | $1.19M | Buy |
14,823
+400
| +3% | +$32K | 0.12% | 74 |
|
|
2016
Q2 | $1.14M | Sell |
14,423
-400
| -3% | -$30.1K | 0.12% | 75 |
|
|
2016
Q1 | $1.07M | Hold |
14,823
| – | – | 0.12% | 76 |
|
|
2015
Q4 | $1.25M | Hold |
14,823
| – | – | 0.14% | 73 |
|
|
2015
Q3 | $1.24M | Sell |
14,823
-450
| -3% | -$38K | 0.16% | 72 |
|
|
2015
Q2 | $1.27M | Sell |
15,273
-255
| -2% | -$19.4K | 0.15% | 74 |
|
|
2015
Q1 | $1.13M | Buy |
15,528
+200
| +1% | +$14.2K | 0.13% | 76 |
|
|
2014
Q4 | $1.06M | Hold |
15,328
| – | – | 0.13% | 78 |
|
|
2014
Q3 | $994K | Sell |
15,328
-1,650
| -10% | -$104K | 0.12% | 78 |
|
|
2014
Q2 | $1.06M | Hold |
16,978
| – | – | 0.13% | 78 |
|
|
2014
Q1 | $999K | Sell |
16,978
-1,500
| -8% | -$83.7K | 0.12% | 79 |
|
|
2013
Q4 | $942K | Sell |
18,478
-200
| -1% | -$10K | 0.12% | 80 |
|
|
2013
Q3 | $940K | Sell |
18,678
-1,800
| -9% | -$94.2K | 0.13% | 77 |
|
|
2013
Q2 | $1.01M | Buy |
+20,478
| New | +$1.11M | 0.15% | 71 |
|
Other funds holding LLY
Waters Parkerson & Co's LLY Position: Q2 2026 in Review
Waters Parkerson & Co reduced its Eli Lilly (LLY) stake by 0.06% in Q2 2026, selling an estimated $6.13K and leaving 10,667 shares worth $12.8M. The position accounts for 0.63% of the portfolio, ranked #42.
Waters Parkerson & Co first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 3,051 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Waters Parkerson & Co held 10,667 shares of Eli Lilly worth $12.8M as of Q2 2026.
- Waters Parkerson & Co sold 6 Eli Lilly shares in Q2 2026, an estimated $6.13K.
- Eli Lilly made up 0.63% of Waters Parkerson & Co's portfolio in Q2 2026, its #42 holding.
- Waters Parkerson & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
- 3,051 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Waters Parkerson & Co's 13F filing for Q2 2026, filed 30 Jul 2026.